Your browser doesn't support javascript.
loading
Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomised, double-blind, placebo-controlled Phase Ib study.
Sinclair, Rodney; Sharifeh, Sammy; Thackwray, Susan; Lickliter, Jason; Wu, Junlong; Li, Jing; Qi, Bei; Bland-Ward, Philip; Reinhart, Harald.
Affiliation
  • Sinclair R; Sinclair Dermatology, East Melbourne, Victoria, Australia.
  • Sharifeh S; The Bridge Family Practice and Skin Clinic, Halls Head, Western Australia, Australia.
  • Thackwray S; University of Sunshine Coast, Sippy Downs, Queensland, Australia.
  • Lickliter J; Nucleus Network, Royal Brisbane Hospital, Herston, Queensland, Australia.
  • Wu J; Zai Lab (Shanghai) Co., Ltd., Shanghai, China.
  • Li J; Zai Lab (Shanghai) Co., Ltd., Shanghai, China.
  • Qi B; Zai Lab (Shanghai) Co., Ltd., Shanghai, China.
  • Bland-Ward P; Crescendo Biologics Ltd, Cambridge, UK.
  • Reinhart H; Zai Lab (Shanghai) Co., Ltd., Shanghai, China.
Exp Dermatol ; 32(9): 1538-1545, 2023 09.
Article in En | MEDLINE | ID: mdl-37377276
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: Exp Dermatol Journal subject: DERMATOLOGIA Year: 2023 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Psoriasis / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans Language: En Journal: Exp Dermatol Journal subject: DERMATOLOGIA Year: 2023 Type: Article Affiliation country: Australia